Related Experiment Videos
A hospital-based network for hyperlipidaemia management and cardiovascular disease prevention
A Pujia1,
1Dipartimento di Medicina Sperimentale e Clinica, Università di Catanzaro, Via T. Campanella, 88100 Catanzaro, Italy. pujia@unicz.it
Insights
A new organizational model bridges the gap between scientific evidence and clinical practice for cardiovascular disease prevention. This hospital-based network standardizes care and improves patient outcomes by implementing clinical guidelines for hyperlipidaemia management.
Area of Science:
- Cardiology
- Public Health
- Health Services Research
Background:
- A significant gap exists between scientific evidence and clinical practice, particularly in post-myocardial infarction care.
- Less than 50% of myocardial infarction survivors receive recommended lipid-lowering therapy.
Purpose of the Study:
- To develop and implement an organizational model to bridge the evidence-practice gap.
- To improve the implementation of clinical guidelines in a real-world clinical setting.
Main Methods:
- Established 23 hyperlipidaemia management and cardiovascular disease prevention clinics.
- Implemented staff training, standardized medical records, and operating protocols.
- Engaged general practitioners and the community, established a freephone number, and standardized quality control.
Main Results:
- The regional clinical network examined 1534 patients, with polygenic hypercholesterolaemia being the most frequent condition.
- Fifty-three percent of patients achieved target cholesterol levels (< 220 mg/dL) within two months of follow-up.
Conclusions:
- The hospital-based network effectively standardizes diagnostic and therapeutic procedures according to guidelines.
- The model has an educational impact on patients and healthcare staff, facilitating evidence-based practice.
- The network serves as a regional reference, improving quality control, drug safety surveillance, and clinical research.
Background And Aim:
A number of studies have shown that there is a wide gap between scientific evidence and clinical practice. In particular, less than 50% of the patients surviving a myocardial infarction take lipid lowering agents. We have developed an organisational model designed to bridge this gap and implement clinical guidelines in a clinical setting.
Methods And Results:
We have set up 23 clinics for the management of hyperlipidaemia and the prevention of cardiovascular disease. The procedure for establishing these clinics included the training of health staff, the preparation of a medical record, the development of a standard operating protocol, the presentation of the aims and operating procedure of the network to general practitioners and the community, the institution of a freephone number, and the standardisation of quality control. The regional clinical network was established in 1998, and examined 1534 patients during the first four months. As expected, the most frequent hyperlipoproteinaemia was polygenic hypercholesterolaemia (30% of males and 32% of females). Fifty-three percent of the 270 patients asking for long-term follow-up reached an acceptable target according to the international guidelines (total cholesterol < 220 mg/dL) in the first two months.
Conclusions:
This organisational model takes advantage of hospital units, which devote a fraction of their time to the prevention of cardiovascular disease. The network is useful for standardising diagnostic and therapeutic procedures in accordance with the guidelines, and has an educational impact on both patients and health staff. The availability of a large database of patients with hyperlipoproteinaemia is the basis for quality control, drug safety surveillance, and clinical studies of specific issues or selected patient subgroups. The hospital-based network is an operational reference for all practitioners in the region and helps to integrate efforts aimed at bridging the gap between scientific evidence and clinical practice.